Anemia and perioperative red blood cell transfusion: A matter of tolerance

Critical Care Medicine

Volumn 34, Issue 5 SUPPL., 2006, Pages

  Madjdpour, Caveh ^a   Spahn, Donat R ^a   Weiskopf, Richard B ^b,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Hemoglobin concentration; Oxygen delivery; Transfusion

Indexed keywords

HEMOGLOBIN;

ANEMIA; BLOOD FLOW VELOCITY; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR RISK; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; HEART MUSCLE CONTRACTILITY; HEMATOCRIT; HIGH RISK PATIENT; HUMAN; HYPOVOLEMIA; IMMUNOLOGICAL TOLERANCE; KIDNEY PERFUSION; OXYGEN DISSOCIATION CURVE; OXYGEN TRANSPORT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW;

EID: 33646379367     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000214317.26717.73     Document Type: Article

References (64)

1. Marcucci C, Madjdpour C, Spahn DR: Allogeneic blood transfusions: Benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull 2004; 70:15-28
2. Goodnough LT: Risks of blood transfusion. Crit Care Med 2003; 31:8678-8686
3. Wagner SJ: Transfusion-transmitted bacterial infection: Risks, sources and interventions. Vox Sang 2004; 86:157-163
4. Llewelyn CA, Hewitt PE, Knight RS, et al: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363:417-421
5. Peden AH, Head MW, Ritchie DL, et al: Pre-clinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364:527-529
6. Vamvakas EC, Carven JH: Allogeneic blood transfusion, hospital charges, and length of hospitalization: A study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 1998; 122:145-151
7. Vamvakas EC: Transfusion-associated cancer recurrence and postoperative infection: Meta-analysis of randomized, controlled clinical trials. Transfusion 1996; 36:175-186
8. Vamvakas EC, Carven JH: Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: Effect of the length of storage of transfused red cells. Transfusion 1999; 39:701-710
9. Carson JL, Altman DG, Duff A, et al: Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39:694-700
10. Kleinman S, Chan P, Robillard P: Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 2003; 17:120-162
11. Webert KE, Blajchman MA: Transfusion-related acute lung injury. Transfus Med Rev 2003; 17:252-262
12. Toy P, Popovsky MA, Abraham E, et al: Transfusion-related acute lung injury: Definition and review. Crit Care Med 2005; 33:721-726
13. Jamnicki M, Kocian R, van der Linden P, et al: Acute normovolemic hemodilution: Physiology, limitations, and clinical use. J Cardiothorac Vasc Anesth 2003; 17:747-754
14. Lieberman JA, Weiskopf RB, Kelley SD, et al: Critical oxygen delivery in conscious humans is less than 7.3 mL 02 X kg(-1) X min(-1). Anesthesiology 2000; 92:407-413
15. Cain SM: Appearance of excess lactate in anesthetized dogs during anemic and hypoxic hypoxia. Am J Physiol 1965; 209:604-610
16. Hebert PC, Van der Linden P, Biro G, et al: Physiologic aspects of anemia. Crit Care Clin 2004; 20:187-212
17. Morisaki H, Sibbald WJ: Tissue oxygen delivery and the microcirculation. Crit Care Clin 2004; 20:213-223
18. Weiskopf RB, Viele MK, Feiner J, et al: Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279:217-221
19. Habler O, Kleen M, Podtschaske A, et al: The effect of acute normovolemic hemodilution (ANH) on myocardial contractility in anesthetized dogs. Anesth Analg 1996; 83:451-458
20. Weiskopf RB, Feiner J, Hopf H, et al: Heart rate increases linearly in response to acute isovolemic anemia. Transfusion 2003; 43:235-240
21. Ickx BE, Rigolet M, Van Der Linden PJ: Cardiovascular and metabolic response to acute normovolemic anemia. Effects of anesthesia. Anesthesiology 2000; 93:1011-1016
22. Spahn DR, Leone BJ, Reves JG, et al: Cardiovascular and coronary physiology of acute isovolemic hemodilution: A review of non-oxygen-carrying and oxygen-carrying solutions. Anesth Analg 1994; 78:1000-1021
23. Spahn DR, Zollinger A, Schlumpf RB, et al: Hemodilution tolerance in elderly patients without known cardiac disease. Anesth Analg 1996; 82:681-686
24. Spahn DR, Seifert B, Pasch T, et al: Effects of chronic beta-blockade on compensatory mechanisms during acute isovolaemic haemodilution in patients with coronary artery disease. Br J Anaesth 1997; 78:381-385
25. Jan KM, Chien S: Effect of hematocrit variations on coronary hemodynamics and oxygen utilization. Am J Physiol 1977; 233:H106-H113
26. von Restorff W, Hofling B, Holtz J, et al: Effect of increased blood fluidity through hemodilution on coronary circulation at rest and during exercise in dogs. Pflugers Arch 1975; 357:15-24
27. Spahn DR, Schmid ER, Seifert B, et al: Hemodilution tolerance in patients with coronary artery disease who are receiving chronic beta-adrenergic blocker therapy. Anesth Analg 1996; 82:687-694
28. Licker M, Ellenberger C, Sierra J, et al: Cardiovascular response to acute normovolemic hemodilution in patients with coronary artery diseases: Assessment with transesophageal echocardiography. Crit Care Med 2005; 33:591-597
29. Garcia MJ, Smedira NG, Greenberg NL, et al: Color M-mode Doppler flow propagation velocity is a preload insensitive index of left ventricular relaxation: Animal and human validation. J Am Coll Cardiol 2000; 35:201-208
30. Nozaki J, Kitahata H, Tanaka K, et al: The effects of acute normovolemic hemodilution on left ventricular systolic and diastolic function in the absence or presence of beta-adrenergic blockade in dogs. Anesth Analg 2002; 94:1120-1126
31. Eagle KA, Berger PB, Calkins H, et al: ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - Executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002; 105:1257-1267
32. Licker M, Ellenberger C, Sierra J, et al: Cardioprotective effects of acute normovolemic hemodilution in patients undergoing coronary artery bypass surgery. Chest 2005; 128:838-847
33. Licker M, Mariethoz E, Costa MJ, et al: Cardioprotective effects of acute isovolemic hemodilution in a rat model of transient coronary occlusion. Crit Care Med 2005; 33:2302-2308
34. Hebert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340:409-417
35. Hebert PC, Yetisir E, Martin C, et al: Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001; 29:227-234
36. Rao SV, Jollis JG, Harrington RA, et al: Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292:1555-1562
37. Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS). Available at: www.ClinicalTrials.gov, Identifier: NCT00071032. Accessed March 14, 2006.
38. Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot. Available at: www.ClinicalTrials.gov, Identifier: NCT00126334. Accessed March 14, 2006.
39. Levy PS, Kim SJ, Eckel PK, et al: Limit to cardiac compensation during acute isovolemic hemodilution: Influence of coronary stenosis. Am J Physiol 1993; 265:H340-H349
40. Spahn DR, Smith LR, Veronee CD, et al: Acute isovolemic hemodilution and blood transfusion. Effects on regional function and metabolism in myocardium with compromised coronary blood flow. J Thorac Cardiovasc Surg 1993; 105:694-704
41. Licker M, Ellenberger C, Murith N, et al: Cardiovascular response to acute normovolaemic haemodilution in patients with severe aortic stenosis: Assessment with transoesophageal echocardiography. Anaesthesia 2004; 59:1170-1177
42. Spahn DR, Seifert B, Pasch T, et al: Haemodilution tolerance in patients with mitral regurgitation. Anaesthesia 1998; 53:20-24
43. Weiskopf RB, Kramer JH, Viele M, et al: Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 2000; 92:1646-1652
44. Weiskopf RB, Feiner J, Hopf HW, et al: Oxygen reverses deficits of cognitive function and memory and increased heart rate induced by acute severe isovolemic anemia. Anesthesiology 2002; 96:871-877
45. Weiskopf RB, Feiner J, Hopf H, et al: Fresh blood and age stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology, In Press
46. Weiskopf RB, Aminoff MJ, Hopf HW, et al: Acute isovolemic anemia does not impair peripheral or central nerve conduction. Anesthesiology 2003; 99:546-551
47. Weiskopf RB, Toy P, Hopf HW, et al: Acute isovolemic anemia impairs central processing as determined by P300 latency. Clin Neurophysiol 2005; 116:1028-1032
48. Deem S, Hedges RG, McKinney S, et al: Mechanisms of improvement in pulmonary gas exchange during isovolemic hemodilution. J Appl Physiol 1999; 87:132-141
49. Borst MM, Leschke M, Konig U, et al: Repetitive hemodilution in chronic obstructive pulmonary disease and pulmonary hypertension: Effects on pulmonary hemodynamics, gas exchange, and exercise capacity. Respiration 1999; 66:225-232
50. Habler O, Kleen M, Hutter J, et al: Effects of hemodilution on splanchnic perfusion and hepatorenal function. II. Renal perfusion and hepatorenal function. Eur J Med Res 1997; 2:419-424
51. Meier J, Pape A, Kleen M, et al: Regional blood flow during hyperoxic haemodilution. Clin Physiol Funct Imaging 2005; 25:158-165
52. Torres Filho IP, Spiess BD, Pittman RN, et al: Experimental analysis of critical oxygen delivery. Am J Physiol Heart Circ Physiol 2005; 288:H1071-H1079
53. Dodd RY, Notari EP IV, Stramer SL: Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42:975-979
54. Moore A, Herrera G, Nyamongo J, et al: Estimated risk of HIV transmission by blood transfusion in Kenya. Lancet 2001; 358:657-660
55. Candotti D, Sarkodie F, Allain JP: Residual risk of transfusion in Ghana. Br J Haematol 2001; 113:37-39
56. Allain JP, Candotti D, Soldan K, et al: The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 2003; 101:2419-2425
57. Kinde G, Oke J, Gnahoui I, et al: The risk of malaria transmission by blood transfusion at Cotonou, Benin. Sante 2000; 10:389-392
58. Innerhofer PKG: Immunomodulation mechanisms following transfusion of allogeneic and autologous erythrocyte concentrates. Infus Ther Transfus Med 2002; 29:118-121
59. Klein HG: Immunomodulatory aspects of transfusion: A once and future risk? Anesthesiology 1999; 91:861-865
60. Kleinman S, Caulfield T, Chan P, et al: Toward an understanding of transfusion-related acute lung injury: Statement of a consensus panel. Transfusion 2004; 44:1774-1789
61. Spahn DR: Strategies for transfusion therapy. Best Pract Res Clin Anaesthesiol 2004; 18:661-673
62. Spahn DR, Dettori N, Kocian R, et al: Transfusion in the cardiac patient. Crit Care Clin 2004; 20:269-279
63. Practice guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84:732-747
64. Simon TL, Alverson DC, AuBuchon J, et al: Practice parameter for the use of red blood cell transfusions: Developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1998; 122:130-138